RREP coordinating organization
This project establishes Results for Development (R4D) as the coordinating organization for the Rapid and Responsive Evidence Partnership (RREP).
This project establishes Results for Development (R4D) as the coordinating organization for the Rapid and Responsive Evidence Partnership (RREP).
IDRC’s response to the COVID-19 crisis includes a rapid response to the food and nutritional security crisis associated with COVID-19.
Little is known about the behavioural and environmental risk factors of COVID-19 because of a lack of high-quality epidemiological data.
Building on their existing commitments to advance the timely and effective use of evidence in policy and decision-making, The William and Flora Hewlett Foundation and IDRC have jointly increased their support to the Rapid and Responsive Evidence P
The Global Partnership for Education (GPE) and IDRC launched the Knowledge and Innovation Exchange (KIX) to improve policies and practices that will strengthen national education systems within GPE partner countries.
This project will enhance the use of data from existing household surveys by government officials to analyze the education sector and encourage policymakers to leverage the resulting knowledge on gender, equity, and inclusion to inform their polic
There is a significant gap in data concerning the patterns and drivers of transactional sex, sexual exploitation, and abuse in transactional sex and their implications on the sexual and reproductive health and rights of refugees.
Recent outbreaks of the highly infectious and dangerous Ebola virus in West and Central Africa underscore the importance of rapid diagnostics and surveillance infrastructure, evidence-driven health communications and community engagement activitie
Despite the well-acknowledged importance of using evidence for decision-making by many development actors, organizations in most countries are not using timely and responsive mechanisms to effectively support evidence-informed policymaking.
The 2013-2015 outbreak of Ebola virus disease (EVD) in West Africa (Guinea, Liberia, and Sierra Leone) was unprecedented, resulting in more than 11,000 human deaths with an estimated total cost of US$4.3 billion.